CSIMarket Company Name, Ticker, Suppliers, else..
 
Oragenics Inc   (NYSE: OGEN)
 

Oragenics Inc's Suppliers Performance

OGEN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
OGEN Costs vs Sales of Suppliers Growth

• More on OGEN Suppliers






Oragenics Inc's Comment on Supply Chain


The company sources raw materials for its product candidates from biological origins, which are difficult to obtain and may be subject to contamination or recall. Access to sufficient quantities that meet technical specifications is often limited to single-source suppliers. Identifying alternative suppliers can be time-consuming and costly due to product characteristics and regulatory approval requirements. Inability to procure necessary raw materials on acceptable terms, in a timely manner, or in adequate quantities may hinder the company's capacity to produce sufficient product quantities for clinical or commercial purposes. Material shortages, contamination, recalls, or restrictions on biologically derived substances could disrupt manufacturing and adversely affect revenue generation from product sales if approved.

Oragenics Inc's Comment on Supply Chain


The company sources raw materials for its product candidates from biological origins, which are difficult to obtain and may be subject to contamination or recall. Access to sufficient quantities that meet technical specifications is often limited to single-source suppliers. Identifying alternative suppliers can be time-consuming and costly due to product characteristics and regulatory approval requirements. Inability to procure necessary raw materials on acceptable terms, in a timely manner, or in adequate quantities may hinder the company's capacity to produce sufficient product quantities for clinical or commercial purposes. Material shortages, contamination, recalls, or restrictions on biologically derived substances could disrupt manufacturing and adversely affect revenue generation from product sales if approved.







OGEN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Oragenics Inc 2.25 0.22 -10.08 3
SUBTOTAL 0.00 0.00 0.00 -


Sources: Oragenics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Oragenics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.